General Information
Version
8.5
Revision date
2024-01-16
Product name
Lovastatin Impurity D
CAS No.
149756-62-7
REACH No
A
Emergency telephone
+44 (0)870 8200418
Icons in SDS
Company Information
company name
Merck Life Science UK Limited
e-mail address of the competent person responsible for the Safety Data Sheet
TechnicalService@merckgroup.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H351, H361f, H413
Hazard statements
Code
Statements
H351
Suspected of causing cancer
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
Carcinogenicity, (Category 2) H351: Suspected of causing cancer. Reproductive toxicity, (Category H361f: Suspected of damaging fertility. 2) Long-term (chronic) aquatic H413: May cause long lasting harmful hazard, (Category 4) effects to aquatic life.
Signal word
Warning Warning
Hazard statements
H351 Suspected of causing cancer. H361f Suspected of damaging fertility. H413 May cause long lasting harmful effects to aquatic life. H413 May cause long lasting harmful effects to aquatic life. H351 Suspected of causing cancer. H361f Suspected of damaging fertility.
Precautionary statements
P201 Obtain special instructions before use. P273 Avoid release to the environment. P308 + P313 IF exposed or concerned: Get medical advice/ attention. P201 Obtain special instructions before use. P308 + P313 IF exposed or concerned: Get medical advice/ attention.
Supplemental label elements
none Reduced Labeling (<= 125 ml) none
Other hazards
This substance/mixture contains no components considered to be either persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) at levels of 0.1% or higher
